Download PDF
Neurologie up2date 2021; 04(04): 325-339
DOI: 10.1055/a-1210-7737
Bewegungsstörungen

Fahrtauglichkeit bei Parkinson-Erkrankung

Carsten Buhmann
1   Ambulanzzentrum Bereich Neurologie und Klinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Die Einschätzung der Fahrtauglichkeit bei Patienten mit Parkinson-Erkrankung ist im Praxisalltag wichtig, aber schwierig und wird oft sowohl von Patienten als auch Ärzten ungern thematisiert. Dieser Beitrag zeigt, welche medizinischen Aspekte eine verminderte Fahrkompetenz entweder als fehlende generelle Fahrtauglichkeit oder als temporär eingeschränkte Fahrfähigkeit anzeigen, welche juristischen Aspekte der Arzt berücksichtigen muss und schlägt ein praxisnahes Vorgehen zur Abklärung der Fahrkompetenz vor.

Schlüsselwörter

Morbus Parkinson - Auto fahren - Führerschein - Fahrtauglichkeit - Fahrfähigkeit - Kraftfahrzeug


Publication History

Article published online:
06 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Meindorfner C, Korner Y, Moller JC. et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20: 832-842
    CrossrefPubMedSearch in Google Scholar
  • 2 Buhmann C, Vettorazzi E, Oehlwein C. et al. Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson's Disease. Parkinsons Dis 2015;
    CrossrefPubMedSearch in Google Scholar
  • 3 Cordell R, Lee HC, Granger A. et al. Driving assessment in Parkinson’s disease – a novel predictor of performance?. Mov Disord 2008; 23: 1217-1222
    CrossrefPubMedSearch in Google Scholar
  • 4 Uc EY, Rizzo M, Johnson AM. et al. Road safety in drivers with Parkinson disease. Neurology 2009; 73: 2112-2119
    CrossrefPubMedSearch in Google Scholar
  • 5 Wood JM, Worringham C, Kerr G. et al. Quantitative assessment of driving performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2005; 76: 176-180
    CrossrefPubMedSearch in Google Scholar
  • 6 Crizzle AM, Classen S, Uc EY. Parkinson disease and driving: An evidence-based review. Neurology 2012; 79: 2067-2074
    CrossrefPubMedSearch in Google Scholar
  • 7 Gräcmann N, Albrecht M. Bundesanstalt für Straßenwesen (BASt). Begutachtungs-Leitlinien zur Kraftfahrereignung. Letzte Änderung am 2. November 2009. Carl Schünemann Verlag GmbH; 2010
    Search in Google Scholar
  • 8 Heikkila VM, Turkka J, Korpelainen J. et al. Decreased driving ability in people with Parkinson’s disease. J Neurol Neurosurg Psychiat 1998; 64: 325-330
    CrossrefPubMedSearch in Google Scholar
  • 9 Klimkeit EI, Bradshaw JL, Charlton J. et al. Driving ability in Parkinson’s disease: current status of research. Neurosci Biobehav Rev 2009; 33: 223-231
    CrossrefPubMedSearch in Google Scholar
  • 10 Buhmann C, Gerloff C. Autofahren bei Morbus Parkinson. Akt Neurol 2013; 40: 315-320
    Thieme ConnectSearch in Google Scholar
  • 11 Mattern R, Körner Y, Wagenpfeil T. Fahrtüchtigkeit bei chronischen Erkrankungen – Ärzte in der Pflicht. Dtsch Med Wochenschr 2006; 131: 2200-2201
    Search in Google Scholar
  • 12 Berghaus G, Brenner-Hartmann J. Fahreignung, Fahrsicherheit und deren Begutachtung. In: Madea B, Mußhoff F, Berghaus G. Verkehrsmedizin: Fahreignung, Fahrsicherheit, Unfallrekonstruktion. Köln: Deutscher Ärzte-Verlag; 2012: 131-143
    Search in Google Scholar
  • 13 Gaidzik P. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik P. Begutachtungen in der Neurologie. Stuttgart: Georg Thieme Verlag; 2011: 258-259
    Search in Google Scholar
  • 14 Landesärztekammer Baden-Württemberg mit den Bezirksärztekammern. Merkblatt – Die Aufklärungspflichen des Arztes – Stand Februar 2016 (Zugriff am 31.10.2021). https://www.aerztekammer-bw.de/10aerzte/40merkblaetter/10merkblaetter/aufklaerungspflicht.pdf
  • 15 Rauschelbach H-H, Jochheim K-A. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik PW. Begutachtung in der Neurologie. Stuttgart: Thieme; 2011: 258
    Search in Google Scholar
  • 16 Fries W, Netz J, Bötzel K. et al. Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Akt Neurol 2005; 32: 342-350
    Thieme ConnectSearch in Google Scholar
  • 17 Singh R, Pentland B, Hunter J. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 2007; 78: 363-366
    CrossrefPubMedSearch in Google Scholar
  • 18 Dubinsky RM, Gray C, Husted D. et al. Driving in Parkinson’s disease. Neurology 1991; 41: 517-520
    CrossrefPubMedSearch in Google Scholar
  • 19 Worringham CJ, Wood JM, Kerr GK. et al. Predictors of driving assessment outcome in Parkinson’s disease. Mov Disord 2006; 21: 230-235
    CrossrefPubMedSearch in Google Scholar
  • 20 Uc EY, Rizzo M, Anderson SW. et al. Driving under low-contrast visibility conditions in Parkinson disease. Neurology 2009; 73: 1103-1110
    CrossrefPubMedSearch in Google Scholar
  • 21 Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 2016; 15: 1257-1272
    CrossrefPubMedSearch in Google Scholar
  • 22 Hirtz D, Thurman DJ, Gwinn-Hardy K. et al. How common are the „common“ neurologic disorders?. Neurology 2007; 68: 326-337
    CrossrefPubMedSearch in Google Scholar
  • 23 Uc EY, Rizzo M. Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 2008; 8: 377-383
    CrossrefPubMedSearch in Google Scholar
  • 24 Man-Son-Hing M, Marshall SC, Molnar FJ. et al. Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia. J Am Geriatr Soc 2007; 55: 878-884
    CrossrefPubMedSearch in Google Scholar
  • 25 Ranchet M, Broussolle E, Paire-Ficout L. Longitudinal executive changes in drivers with parkinson’s disease: study using neuropsychological and driving simulator tasks. Eur Neurol 2016; 76: 143-150
    CrossrefPubMedSearch in Google Scholar
  • 26 Devos H, Vandenberghe W, Tant M. et al. Driving and off-road impairments underlying failure on road testing in Parkinson’s disease. Mov Disord 2013; 28: 1949-1956
    CrossrefPubMedSearch in Google Scholar
  • 27 Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson’s disease patients. Arch Clin Neuropsychol 2007; 22: 957-967
    CrossrefPubMedSearch in Google Scholar
  • 28 Archibald NK, Clarke MP, Mosimann UP. et al. Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 2011; 26: 2387-2395
    CrossrefPubMedSearch in Google Scholar
  • 29 Uc EY, Rizzo M, Anderson SW. et al. Impaired visual search in drivers with Parkinson’s disease. Ann Neurol 2006; 60: 407-413
    CrossrefPubMedSearch in Google Scholar
  • 30 Archibald NK, Hutton SB, Clarke MP. et al. Visual exploration in Parkinson’s disease and Parkinson’s disease dementia. Brain 2013; 136: 739-750
    CrossrefPubMedSearch in Google Scholar
  • 31 Chaudhuri KR, Prieto-Jurcynska C, Naidu Y. et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 704-709
    CrossrefPubMedSearch in Google Scholar
  • 32 Uitti RJ. Parkinson’s disease and issues related to driving. Parkinsonism Relat Disord 2009; 15 (Suppl. 03) 122-125
    CrossrefPubMedSearch in Google Scholar
  • 33 Crucian GP, Armaghani S, Armaghani A. et al. Visual-spatial disembedding in Parkinson’s disease. J Clin Exp Neuropsychol 2010; 32: 190-200
    CrossrefPubMedSearch in Google Scholar
  • 34 Uc EY, Rizzo M, Johnson AM. et al. Real-life driving outcomes in Parkinson disease. Neurology 2011; 76: 1894-1902
    CrossrefPubMedSearch in Google Scholar
  • 35 Madeley P, Hulley JL, Wildgust H. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 1990; 53: 580-582
    CrossrefPubMedSearch in Google Scholar
  • 36 Lings S, Dupont E. Driving with Parkinson’s disease. A controlled laboratory investigation. Acta Neurol Scand 1992; 86: 33-39
    CrossrefPubMedSearch in Google Scholar
  • 37 Zesiewicz TA, Cimino CR, Malek AR. et al. Driving safety in Parkinson’s disease. Neurology 2002; 59: 1787-1788
    CrossrefPubMedSearch in Google Scholar
  • 38 Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102
    CrossrefPubMedSearch in Google Scholar
  • 39 Ondo WG, Dat VK, Khan H. et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001; 57: 1392-1396
    CrossrefPubMedSearch in Google Scholar
  • 40 Paus S, Brecht HM, Koster J. et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003; 18: 659-667
    CrossrefPubMedSearch in Google Scholar
  • 41 Weintraub D, Koester J, Potenza MN. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595
    CrossrefPubMedSearch in Google Scholar
  • 42 Avanzi M, Baratti M, Cabrini S. et al. The thrill of reckless driving in patients with Parkinson’s disease: an additional behavioural phenomenon in dopamine dysregulation syndrome?. Parkinsonism Relat Disord 2008; 14: 257-258
    CrossrefPubMedSearch in Google Scholar
  • 43 Parsons TD, Rogers SA, Braaten AJ. et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588
    CrossrefPubMedSearch in Google Scholar
  • 44 Witt K, Daniels C, Reiff J. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614
    CrossrefPubMedSearch in Google Scholar
  • 45 Cavanagh JF, Wiecki TV, Cohen MX. et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011; 14: 1462-1467
    CrossrefPubMedSearch in Google Scholar
  • 46 Frank MJ, Samanta J, Moustafa AA. et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312
    CrossrefPubMedSearch in Google Scholar
  • 47 Buhmann C, Maintz L, Hierling J. et al. Effect of subthalamic nucleus deep brain stimulation on driving in Parkinson disease. Neurology 2014; 82: 32-40
    CrossrefPubMedSearch in Google Scholar
  • 48 Buhmann C, Gerloff C. Could deep brain stimulation help with driving for patients with Parkinson’s?. Expert Rev Med Devices 2014; 11: 427-429
    CrossrefPubMedSearch in Google Scholar
  • 49 Buhmann C, Oelsner H, Vesper J. Neurologische Leitlinie „Tiefe Hirnstimulation (THS) und Autofahren bei Morbus Parkinson“ der Arbeitsgemeinschaft Tiefe Hirnstimulation e.V. 2017
    PubMedSearch in Google Scholar
  • 50 Schubert W, Schneider W, Eisenmenger W. et al. Begutachtungsleitlinien zur Kraftfahrereignung – Kommentar. 2. Aufl. Bonn: Kirschbaum; 2005
    Search in Google Scholar
  • 51 Fründt O, Fadhel M, Heesen C. et al. Do impulse control disorders impair car driving performance in patients with Parkinson’s disease? submitted.
  • 52 Buhmann C, Vesper J, Oelsner H. Fahreignung bei Morbus Parkinson: Driving ability in Parkinson’s disease. Fortschr Neurol Psych 2018; 86: 43-48
    Thieme ConnectPubMedSearch in Google Scholar
  • 53 Classen S, Witter DP, Lanford DN. et al. Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease. Am J Occup Ther 2011; 65: 579-588
    CrossrefPubMedSearch in Google Scholar
  • 54 Lachenmayer L. Parkinson’s disease and the ability to drive. J Neurol 2000; 247 (Suppl. 04) IV/28-IV/30
    CrossrefPubMedSearch in Google Scholar